Inspire Medical Accelerates $75M Stock Repurchase as Part of $150M Buyback Plan
Inspire Medical Accelerates $75M Stock Repurchase as Part of $150M Buyback Plan
Inspire Medical Systems, Inc. (NYSE:INSP) ("Inspire," or the "Company"), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today announced that it entered into an accelerated share repurchase ("ASR") transaction under an agreement with Goldman Sachs & Co. LLC, to repurchase an aggregate of $75.0 million of shares of the Company's common stock, par value $0.001 per share. The ASR transaction is being completed pursuant to a previously announced $150.0 million share repurchase program authorized by the Company's Board of Directors.
Inspire醫療系統公司（紐交所：INSP）（"Inspire"或"公司"），一家專注於開發和推廣創新的、微創解決方案，用於阻塞性睡眠呼吸暫停患者的醫療科技公司，今天宣佈與高盛的高盛公司達成協議，進行了一項加速股份回購（ASR）交易，以回購公司普通股股票總額爲7500萬美元，每股面值爲0.001美元。 ASR交易根據公司董事會授權的15000萬美元股份回購計劃完成。
譯文內容由第三人軟體翻譯。